Innoplexus Inc., the Hoboken-based subsidiary of German drug discovery and development platform Innoplexus AG, said it has named a new senior vice president and chief technology officer.
Stratos Davlos, who has more than 20 years of leadership experience in artificial intelligence and machine learning, joins Innoplexus from the Watson, AI & Engineering unit at IBM.
“We are very excited to welcome Stratos to Innoplexus at such an important time, as we roll out our AI-powered platform for drug discovery and development for various industry stakeholders,” founder and CEO Gunjan Bhardwaj said in a prepared statement. “His expertise and extensive experience will help us accelerate scaling our AI.”
Davlos will be based in California in his global role, and is tasked with building a research lab in the Silicon Valley.
“I am excited to be a part of a purpose-driven company, and continue to innovate with AI for effective and efficient drug discovery,” he said in a statement. “Together with Innoplexus, we will put a dent in the universe for the service of humanity.”
